Joep Killestein and Chris Polman

The therapeutic value of cannabinoids in MS: real or imaginary?
Mult Scler 2004 10: 339-340. [PDF] [References]  

Filippo Martinelli Boneschi, Marco Rovaris, Giancarlo Comi, and Massimo Filippi

The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials
Mult Scler 2004 10: 341-347. [Abstract] [PDF] [References]  

A Rotola, I Merlotti, L Caniatti, E Caselli, E Granieri, M R Tola, D Di Luca, and E Cassai

Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease
Mult Scler 2004 10: 348-354. [Abstract] [PDF] [References]  

P W Tuke, S Hawke, P D Griffiths, and D A Clark

Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains
Mult Scler 2004 10: 355-359. [Abstract] [PDF] [References]  

C Contini, R Cultrera, S Seraceni, M Castellazzi, E Granieri, and E Fainardi

Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis
Mult Scler 2004 10: 360-369. [Abstract] [PDF] [References]  

Paul W Denton, Christina M Tello, and Roger W Melvold

CD8 + T cells reduce in vitro interferon-g production in Theiler’s murine encephalomyelitis virus-induced demyelinating disease model
Mult Scler 2004 10: 370-375. [Abstract] [PDF] [References]  

J Sastre-Garriga, M Comabella, L Brieva, A Rovira, M Tintoré, and X Montalban

Decreased MMP-9 production in primary progressive multiple sclerosis patients
Mult Scler 2004 10: 376-380. [Abstract] [PDF] [References]  

S Al-Shammri, R F Nelson, I Al-Muzairi, and A O Akanji

HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population
Mult Scler 2004 10: 381-386. [Abstract] [PDF] [References]  

D T Chard, C M Griffin, W Rashid, G R Davies, D R Altmann, R Kapoor, G J Barker, A J Thompson, and D H Miller

Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis
Mult Scler 2004 10: 387-391. [Abstract] [PDF] [References]  

Bernard D Coombs, Alan Best, Mark S Brown, David E Miller, John Corboy, Monika Baier, and Jack H Simon

Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging
Mult Scler 2004 10: 392-397. [Abstract] [PDF] [References]  

V L Stevenson, G T Ingle, D H Miller, and A J Thompson

Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study
Mult Scler 2004 10: 398-401. [Abstract] [PDF] [References]  

Xingchang Wei, Charles RG Guttmann, Simon K Warfield, Michael Eliasziw, and J Ross Mitchell

Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed?
Mult Scler 2004 10: 402-406. [Abstract] [PDF] [References]  

M Debouverie, N Vandenberghe, S P Morrissey, R Anxionnat, S Pittion-Vouyovitch, H Vespignani, and G Edan

Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis
Mult Scler 2004 10: 407-412. [Abstract] [PDF] [References]  

Carlos Nos, Jaume Sastre-Garriga, Cecília Borrlàs, Jordi Río, Mar Tintoré, and Xavier Montalban

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis
Mult Scler 2004 10: 413-416. [Abstract] [PDF] [References]  

C Vaney, M Heinzel-Gutenbrunner, P Jobin, F Tschopp, B Gattlen, U Hagen, M Schnelle, and M Reif

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
Mult Scler 2004 10: 417-424. [Abstract] [PDF] [References]  

C M Brady, R DasGupta, C Dalton, O J Wiseman, K J Berkley, and C J Fowler

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
Mult Scler 2004 10: 425-433. [Abstract] [PDF] [References]  

Derick T Wade, Petra Makela, Philip Robson, Heather House, and Cynthia Bateman

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
Mult Scler 2004 10: 434-441. [Abstract] [PDF] [References]  

C Pozzilli, L Palmisano, C Mainero, V Tomassini, F Marinelli, G Ristori, C Gasperini, M Fabiani, and M A Battaglia

Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis
Mult Scler 2004 10: 442-446. [Abstract] [PDF] [References]  

L Nicholl, J Hobart, L Dunwoody, F Cramp, and A Lowe-Strong

Measuring disability in multiple sclerosis: is the Community Dependency Index an improvement on the Barthel Index?
Mult Scler 2004 10: 447-450. [Abstract] [PDF] [References]  

M J Tullman, R J Oshinsky, F D Lublin, and G R Cutter

Clinical characteristics of progressive relapsing multiple sclerosis
Mult Scler 2004 10: 451-454. [Abstract] [PDF] [References]  

Diane Borello-France, Wendy Leng, Margie O'Leary, Macrina Xavier, Janet Erickson, Michael B Chancellor, and Tracy W Cannon

Bladder and sexual function among women with multiple sclerosis
Mult Scler 2004 10: 455-461. [Abstract] [PDF] [References]  

Alfredo Romani, Roberto Bergamaschi, Elisa Candeloro, Enrico Alfonsi, Roberto Callieco, and Vittorio Cosi

Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment
Mult Scler 2004 10: 462-468. [Abstract] [PDF] [References]  

Magnus Vrethem, Ingrid Fernlund, Jan Ernerudh, and Sten Öhman

Prognostic value of cerebrospinal fluid IgA and IgG in multiple sclerosis
Mult Scler 2004 10: 469-471. [Abstract] [PDF] [References]  

Raymond Voltz, Michaela Starck, Vera Zingler, Michael Strupp, and Hans-Jochem Kolb

Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients
Mult Scler 2004 10: 472-474. [Abstract] [PDF] [References]  

M R Haupts, S Daum, G Ahle, B Holinka, and W Gehlen

Transcranial magnetic stimulation as a provocation for epileptic seizures in multiple sclerosis
Mult Scler 2004 10: 475-476. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.